FBP1 and neoplasm: Finally, it has been demonstrated that the deletion of the gluconeogenesis regulatory enzyme FBP1 (Fructose-1, 6-biphosphatase) induced an increment of the tumor growth, as well as an increase of the anti-PD-L1 treatment resistance [115].